Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Bladder Cancer
Reports summarize bladder cancer research from Oulu University
September 16th, 2008
"Backround: The purpose of this study was to explore whether changes in matrix metalloproteinase-9 (MMP-9) are involved in the Progression of urinary bladder cancer and whether they have any prognostic value. Overexpression of MMP-9 was evaluated in the primary tumor of 87 urinary bladder cancer cases with immunohistochemical staining," scientists writing in the journal Anticancer Research report. "Of the urinary bladder carcinomas, 38% showed an overexpression (>25%) of MMP-9 immunoreactive protein. Increased positivity for MMP-9 correlated with favorable overall survival of the urinary bladder cancer patients. The 5-year overall survival and relapse-free...
Source: Cancer Weekly (2008-09-16)
|
